Cannabis
Motif Labs secures additional growth financing and announces extraction agreement with cultivator JC Green
Motif Labs is pleased to announce an additional $2.65M of Series B investment from existing shareholders to execute on strategic growth objectives. The company has now secured more than $8M in financing to build out it’s cannabis extraction and processing facility in Southwestern Ontario. Within the Phase 1 footprint of 12,500 sqft, Motif will be capable of processing more than 200,000kg of biomass annually. Operations are expected to begin in early 2020. The growth capital will be used to bring additional capacity online, and to add ancillary services including expanded storage, high throughput terpene extraction and bulk water-soluble products, which strengthen Motif’s overall product offering and differentiation in the market.
Extraction Partnership Announced
With its 2020/2021 extraction capacity quickly filling up, Motif announced an extraction agreement with licensed cultivator JC Green. Motif will convert a portion of JC Green’s harvest into highly purified distillate oil, allowing the company to meet its Cannabis 2.0 objectives.
CEO of Motif Labs, Ian Haase, stated that “Motif Labs is thrilled to partner with JC Green and it’s incredible team of cultivation experts. The company has developed a strong brand, with exceptional quality, and we look forward to providing the company with high quality concentrates for the next generation of cannabis products.”
JC Green CEO, Robert O’Neill, stated that “JC Green is extremely fortunate to have an extraction facility of Motif’s caliber so close by our production site. We are excited about the synergy between our two privately owned companies and ecstatic for the future of our budding relationship. Together we will help a maturing cannabis industry better serve our customers and community’s needs.”
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan7 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis3 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis3 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis1 day ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032